Rolziracetam

Rolziracetam is a nootropic drug of the racetam family.

Rolziracetam

Clinical data
Other names	2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione
Routes of administration	Oral
ATC code	none
Legal status
Legal status	AU: S4 (Prescription only) US: Unscheduled
Identifiers
IUPAC name dihydro-1H-pyrrolizine-3,5(2H,6H)-dione
CAS Number	18356-28-0
PubChem CID	71893
ChemSpider	64906
UNII	RES9I0LGG5
ChEMBL	ChEMBL51396
CompTox Dashboard (EPA)	DTXSID80171444
Chemical and physical data
Formula	C7H9N2O2
Molar mass	153.161 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C2N1C(=O)CCC1CC2
InChI InChI=1S/C7H9NO2/c9-6-3-1-5-2-4-7(10)8(5)6/h5H,1-4H2 Key:IEZDOKQWPWZVQF-UHFFFAOYSA-N
(what is this?)  (verify)

Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects.[1]

See also

• Piracetam

References

1. Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG (March 1987). "Amnesia-reversal activity of a series of cyclic imides". Journal of Medicinal Chemistry. 30 (3): 498–503. doi:10.1021/jm00386a010. PMID 3820221.